Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. A close monitoring of [[liver function tests]] is recommended during treatment with [[temozolomide]] ((Grieco A, Tafuri MA, Biolato M, Diletto B, Di Napoli N, Balducci N, Vecchio FM, Miele L. Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature. Medicine (Baltimore). 2015 Mar;94(12):e476. doi: 10.1097/MD.0000000000000476. PMID: 25816026; PMCID: PMC4554001.)) ((Niewald M, Berdel C, Fleckenstein J, Licht N, Ketter R, RĂ¼be C. Toxicity after radiochemotherapy for glioblastoma using temozolomide--a retrospective evaluation. Radiat Oncol. 2011 Oct 21;6:141. doi: 10.1186/1748-717X-6-141. PMID: 22017800; PMCID: PMC3213071.)) ((Goldbecker A, Tryc AB, Raab P, Worthmann H, Herrmann J, Weissenborn K. Hepatic encephalopathy after treatment with temozolomide. J Neurooncol. 2011 May;103(1):163-6. doi: 10.1007/s11060-010-0354-y. Epub 2010 Aug 22. PMID: 20730617.)) liver_function_tests.txt Last modified: 2024/06/07 02:54by 127.0.0.1